ysms or acute
aortic syndromes. The goal of therapy is to reduce the
systolic blood pressure to <20 mm Hg and the heart
rate to <60 beats/min when possible before, during,
and after TEVAR (see exceptions in recommendations
for spinal cord protection). This is usually achieved with
intravenous beta blockers (or alpha/beta blockers) as

ﬁrst-line therapy. For patients who do not respond to or
are intolerant